Clinicopathologic Characteristics of Epstein-Barr Virus-Incorporated Gastric Cancers in Korea
- 1 January 2001
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 197 (6) , 395-400
- https://doi.org/10.1078/0344-0338-00052
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Epstein–Barr virus and gastric carcinoma in Western patients: comparison of pathological parameters and p53 expression in EBV‐positive and negative tumoursHistopathology, 2000
- Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomachJournal of Clinical Pathology, 1998
- Expression of p53 and p21 Are Independent Prognostic Factors in Patients with Serosal Invasion by Gastric CarcinomaDigestive Diseases and Sciences, 1998
- Epstein-Barr-virus-associated gastric cancer in RussiaInternational Journal of Cancer, 1997
- Epstein-barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulationHuman Pathology, 1996
- Epstein-Barr virus-associated gastric adenocarcinoma in TaiwanHuman Pathology, 1995
- Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein.Proceedings of the National Academy of Sciences, 1994
- p53 In tumour pathology: Can we trust immunohistochemistry?—revisited!The Journal of Pathology, 1994
- An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasmsThe Journal of Pathology, 1994
- VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMAThe Lancet, 1964